EUVIMEDEUVIMED entdecken
Crossref

Global Trends and Inequalities in Diabetes Prevalence and Treatment Coverage Among Adults Aged ≥ 45 Years, 1990–2040: Insights From the NCD‐RisC Database

Jinli Liu, Yanan Wang, Lei Zhang iD, Shaonong Dang

Diabetes/Metabolism Research and Reviews · 2026-05 · 42 (4)

DOI: 10.1002/dmrr.70164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes/Metabolism Research and Reviews, online erschienen am 31.03.2026. Verfasst von Jinli Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Global Health, Diabetes Mellitus, Healthcare Disparities. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, the National Key R&D Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To assess the global burden, trends, and inequalities of diabetes prevalence and treatment coverage among adults aged ≥ 45 years from 1990 to 2040. Materials and Methods Diabetes prevalence and treatment coverage data were obtained from the NCD‐RisC database. Average annual percentage changes (AAPC) were estimated using join point regression, and a Bayesian age–period–cohort model was used to project diabetes prevalence and treatment coverage from 2023 to 2040. Cross‐national health inequalities were measured using the slope index of inequality (SII) and the relative concentration index (RCI).

Results

Globally, diabetes prevalence rose from 12.85% in 1990 to 23.57% in 2022 (AAPC = 1.90%), and is projected to reach 37.44% by 2040 (AAPC = 2.59%). Treatment coverage grew from 33.22% to 45.88% (AAPC = 1.02%) and is projected to surge to 51.64% by 2040 (AAPC = 0.65%). Diabetes prevalence grew fastest in middle‐income countries, whereas treatment coverage improved most in higher‐income countries. The SII for prevalence burden decreased from −0.25% in 1990 to −14.86% in 2022, and is projected to further decline to −18.32% by 2040. For treatment coverage, the SII increased from 24.57% in 1990 to 43.91% in 2022, with a projected rise to 54.22% by 2040. The relative inequality measured by the RCI showed a similar pattern.

Conclusion

Between 1990 and 2040, diabetes prevalence is projected to increase significantly, while treatment coverage shows only limited improvement. Over the same period, the diabetes prevalence burden is increasingly concentrated in resource‐limited regions, while treatment accessibility is becoming progressively more concentrated in economically developed areas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Global HealthDiabetes MellitusHealthcare DisparitiesHumansPrevalenceMiddle AgedFemaleMaleDatabases, FactualAgedPrognosisFollow-Up StudiesSocioeconomic Disparities in Health

Stichwörter der Autor:innen

Bayesian age‐period‐cohort modelaverage annual percentage changehealth inequalitiesprevalencetreatment coverage

Autor:innen und Institutionen

  • Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
  • Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, China.
  • Med-X Institute, Center for Immunological and Metabolic Diseases, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Phase I Clinical Trial Research Ward, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
  • Artificial Intelligence and Modelling in Epidemiology Program, Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia.

ORCID-Profile: Lei Zhang

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • the National Key R&D Program of China
  • National Natural Science Foundation of China
  • the China Postdoctoral Foundation Project
  • the Postdoctoral Fellowship Program of CPSF
  • the Natural Science Basic Research Program of Shaanxi Province

Zitieren

APA

Liu, J., Wang, Y., Zhang, L., & Dang, S. (2026). Global Trends and Inequalities in Diabetes Prevalence and Treatment Coverage Among Adults Aged ≥ 45 Years, 1990–2040: Insights From the NCD‐RisC Database. Diabetes/Metabolism Research and Reviews, 42(4). https://doi.org/10.1002/dmrr.70164

Vancouver

Liu J, Wang Y, Zhang L, Dang S. Global Trends and Inequalities in Diabetes Prevalence and Treatment Coverage Among Adults Aged ≥ 45 Years, 1990–2040: Insights From the NCD‐RisC Database. Diabetes/Metabolism Research and Reviews. 2026;42(4). doi:10.1002/dmrr.70164

BibTeX
@article{Liu2026,
  author = {Liu, Jinli and Wang, Yanan and Zhang, Lei and Dang, Shaonong},
  title = {Global Trends and Inequalities in Diabetes Prevalence and Treatment Coverage Among Adults Aged ≥ 45 Years, 1990–2040: Insights From the NCD‐RisC Database},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2026},
  volume = {42},
  number = {4},
  doi = {10.1002/dmrr.70164}
}
Kostenlos starten →